ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00005589
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : September 17, 2013
Sponsor:
Collaborator:
Lymphoma Trials Office
Information provided by:
National Cancer Institute (NCI)